Biolase Technology Inc.
- Share via
The San Clemente medical products company reported a net loss of $1 million, or 6 cents a share, for the first quarter, compared with a net loss of $669,856, or 4 cents a share, for the same period last year. Sales declined 17% to $1.5 million. The company said results were affected by discounting of older products to clear out inventory in preparation for shipment of new dental laser systems.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.